Traditional Chinese medicine study for idiopathic pulmonary fibrosis
Treatments studied
Part of Lungs & breathing clinical trials.
This study follows people with idiopathic pulmonary fibrosis (IPF, a lung scarring disease) to see how traditional Chinese medicine (TCM) might help. You may be able to join if you are at least 40 years old and willing to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with idiopathic pulmonary fibrosis (IPF)
- You are 40 years old or older
- You agree to join the study and sign a consent form
- You do not have confusion, dementia, or other serious mental health conditions
- You are able to care for yourself and are not bedridden for long periods
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the features of idiopathic pulmonary fibrosis (IPF) and the traditional Chinese medicine patterns that go with it. If you have IPF, you may be able to join to help researchers understand the disease better.
This trial tests a new drug called BC006 for people with idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring. The goal is to see if it can help improve lung function. You may be eligible if you are 40 or older and have a confirmed IPF diagnosis with specific lung test results.
This trial tests a new drug called TDI01 to see if it helps people with idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring. You may qualify if you have a confirmed IPF diagnosis and your lung function is stable enough.
This Phase 2 study tests whether an oral medication (INS018_055) can help people with idiopathic pulmonary fibrosis (IPF). You may be a fit if your lung function is in a certain range and your condition is stable.
This trial tests an inhaled drug called LTI-03 to see if it can help people with idiopathic pulmonary fibrosis (IPF). It may be an option for those with moderate lung function who are stable on their current treatment.
This study looks at how traditional Chinese medicine can help people aged 60 and older who have COPD. It aims to see if this approach can improve breathing and quality of life.
Hear when a new Idiopathic Pulmonary Fibrosis (IPF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.